Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan
The Hadassah Medical Organization, using the powerful research tool of advanced gene sequencing, has identified a gene mutation that 3 of a couple’s 12 children shared, which caused them to have an intellectual disability, short stature, seizures, and disturbed glucose metabolism. Now the other healthy children are able to be tested to see if they carry the mutation and to plan their futures.
IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah
“When I saw a young woman on the road, I stopped my car,” relates Yishayahu Horowitz, a medic in the Israel Defense Forces. “At first I thought it was a car accident, but then I realized it was a terror attack.
On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research
“Today we are seeing a revolution in the treatment of melanoma and the Hadassah Medical Center is among the world leaders because we always believed that the immune system can combat cancer,” says Dr. Michal Lotem, head of Hadassah’s Organization for Melanoma and Cancer Immunotherapy.
“He was two and a half months old when I saw him for the first time,” said Hadassah Medical Organization Pediatric Ophthalmologist Dr. Irene Anteby about the East Jerusalem baby who was assumed to be blind. Dr. Anteby, however, realized he wasn’t reacting to light because dense cataracts were blocking his vision.
Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA
Jerusalem’s Cell Cure Neurosciences, whose mission is to become a leading supplier of human cell-based therapies for the treatment of retinal and neurodegenerative diseases, has received approval from the United States Food and Drug Administration (FDA) to conduct a clinical trial to treat the dry form of age-related macular degeneration (AMD) with OpRegen®, a first-of-its kind animal product-free, retinal pigment epithelial (RPE) cell formulation derived from human embryonic stem cells (hESCs).
“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient
Active and independent, doing her own shopping and cooking along with volunteer work in the West Bank city of Bethlehem, 82-year-old Maria suddenly collapsed after she stopped taking her blood thinner to prepare for a dental procedure.
Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General
Describing the Hadassah Medical Organization’s new inpatient facility— the Sarah Wetsman Davidson Hospital Tower— as “a beacon of healing that rises from the Jerusalem hillside,” Acting Director General Prof. Tamar Peretz explained to her New York audience of supporters that “a steering committee of people on both sides of the ocean worked together to plan the best hospital building in the world.”
Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program
Keynoting the colorful 39th graduation ceremony of the International Master of Public Health (IMPH) program of the Hadassah-Hebrew University’s Braun School of Public Health and Community Medicine was 1999 IMPH graduate, Dr. Anna Marzec-Boguslawska, Director of The National AIDS Center, Warsaw, Poland. Her topic was: "Bringing it All Together: Building on the IMPH experience for effective responses to public health threats in an ever-changing world.”
Hadassah Doctor Receives International Prize for Medical Innovation
Prof. Mintz, in cooperation with the Israeli start-up EasyNOTES, recently developed a method to perform a gastric bypass without a single incision or anesthesia, by using an endoscope to place magnets into the small intestine and stomach.
Thousands of weeping Israelis of all ages accompanied Lieutenant Tamar Ariel to her final resting place in Israel’s Moshav Masuot Yitzhak, where her mother, Anat Tuchman Ariel, and her father, Hanan Ariel, met while her mother was on Hadassah’s Young Judaea Year Course.
A Mysterious Case Sends a Family Searching for Cures, Finding Hadassah
Nine-year-old Tasnin had spent most of her life going from doctor to doctor, as one cold and respiratory infection followed the next. For a long time, doctors were unable to diagnose the cause until Hadassah’s genetic experts identified the culprit and cured her--a breakthrough that will be highlighted in one of the world’s top hematology journals in the coming months.
Tasnin, who is the middle daughter of five sisters, was often so sick she had to be hospitalized. But doctors believed it was “just a virus,” and she would outgrow this pattern of continually contracting these respiratory illnesses.
Grateful Patients, Their Families, and Their Doctors Offer Thanks
Barbara Sofer, Hadassah’s Israel Director of Public Relations, has received many warm words of appreciation from grateful patients who want to express their thanks to the hospital’s supporters around the globe.
Head of Hadassah's Hospital Addresses The Economist Health Care Forum
"I was delighted and honored to be invited to such a prestigious meeting,” Dr. Levtzion-Korach relates. "I felt so proud representing Israel in general and Hadassah in particular. Here I was being asked about the Israeli health system, and I knew that the women of Hadassah had initiated it."
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>